Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Kao, Yu Chen ^a   Liu, Yia Ping ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ZOTEPINE;

ADOLESCENT; ADULT; AGE; ARTICLE; BECK DEPRESSION INVENTORY; BECK HOPELESSNESS SCALE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT ATTITUDE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL BEHAVIOR; STRUCTURED INTERVIEW; SUICIDAL IDEATION; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; HOSPITALIZATION; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; PSYCHOSIS; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; AGE OF ONSET; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 77955594629     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-63     Document Type: Article

References (61)

1. Altamura AC. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance. Schizophr Res 1992, 8:187-198.
2. Conley RR, Buchannan RW. Evaluation of treatment-resistant of schizophrenia. Schizophr Bull 1997, 23:663-674.
3. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 2003, 60(6):565-571. 10.1001/archpsyc.60.6.565, 12796219.
4. Hafner H, Hambrecht M, Loffler W, Munk-Jorgensen P, Riecker-Rossler A. Is schizophrenia a disorder of all age? A comparison of first episode and early course across the life-cycle. Psychol Med 1998, 28(2):351-365. 10.1017/S0033291797006399, 9572092.
5. Lindstorm LH. Clinical and biological markers for outcome in schizophrenia. A review of a longitudinal follow-up study in Uppsala. Schizophr Res 1996, 14:23-26.
6. Ciompi L. Learning from outcome studies. Toward a comprehensive biological psychosocial understanding of schizophrenia. Schizophr Res 1988, 1:373-384. 10.1016/0920-9964(88)90018-7, 3154525.
7. Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. Int Clin Psychopharmacol 1998, 13(suppl 3):S21-S26. 10.1097/00004850-199803003-00004, 9690966.
8. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998, 155(9):1196-1201.
9. Eaton WW, Thara R, Federman E, Tien A. Remission and relapse in schizophrenia: the Madras Longitudinal Study. J Nerv Ment Dis 1998, 186(6):357-363. 10.1097/00005053-199806000-00006, 9653420.
10. Robison D, Woerner MG, Alvir JM. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999, 56(3):241-247. 10.1001/archpsyc.56.3.241, 10078501.
11. De Quardo JR. Pharmacologic treatment of first-episode schizophrenia: early intervention is the key to the outcome. J Clin Psychiatry 1998, 59(19):9-17.
12. APA Diagnostic and statistical Manual of Mental Disorders, Fourth Edition. 1994, Washington (DC): American Psychiatric Press, 4, APA.
13. Kendler KS, MacLean CJ. Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Gen Epidemiol 1990, 7:409-417.
14. Sham PC, Jones P, Russell A. Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 1994, 165:466-473. 10.1192/bjp.165.4.466, 7804660.
15. Rapoport JL, Giedd JN, Blumenthai J. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 1999, 56:649-654. 10.1001/archpsyc.56.7.649, 10401513.
16. Loranger AW. Sex difference in age of onset of schizophrenia. Arch Gen Psychiatry 1984, 41:157-161.
17. Vourdas A, Pipe R, Corrigal R, Frangous S. Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr Res 2003, 62:13-22. 10.1016/S0920-9964(02)00429-2, 12765738.
18. Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S. The maudsley early onset schizophrenia study: Cognitive function in adolescents with recent onset schizophrenia. Schizophr Res 2003, 61:137-148. 10.1016/S0920-9964(02)00291-8, 12729865.
19. Nicolson R, Lenane M, Singaracharlu S. Premorbid speech and language impairments in childhood-onset of schizophrenia: Association with risk factors. Am J Psychiatry 2000, 157:794-800. 10.1176/appi.ajp.157.5.794, 10784474.
20. Hoff AL, Harris D, Faustman WO. A neuropsychological study of early onset schizophrenia. Schizophr Res 1996, 20:21-28. 10.1016/0920-9964(95)00065-8, 8794490.
21. Hollis O. Adult outcomes of child- and adolescent-onset schizophrenia: Diagnostic stability and predictive validity. Am J Psychiatry 2000, 157:1652-1659. 10.1176/appi.ajp.157.10.1652, 11007720.
22. Goodwin FK, Jamison KR. Manic-depressive illness. 2007, New York: Oxford University Press, 2.
23. Maj M, Pirozzi R, Formicola AM, Bartoli P. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000, 57:95-98. 10.1016/S0165-0327(99)00059-2, 10708820.
24. Craddock N, O'Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder ? Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16. 10.1093/schbul/sbj033, 2632175, 16319375.
25. Ongur D, Lin L, Cohen BM. Clinical characteristics influencing age at onset in psychotic disorders. Compr Psychiatry 2009, 50:13-19. 10.1016/j.comppsych.2008.06.002, 19059508.
26. Hollis C. Adolescent schizophrenia. Adv Psychiatry 2000, 6:83-92.
27. Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res 2000, 45:203-211. 10.1016/S0920-9964(99)00208-X, 11042438.
28. Kay SR, Fiszbei A, Vital-Herne M, Silva-Fuentes L. The Positive and Negative Syndrome Scale-Spanish adaptation. J Ner Ment Dis 1990, 178:510-517.
29. Evenden J. Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 1999, 13:180-192. 10.1177/026988119901300211, 10475725.
30. Li CH, Ko HC, Weng LJ, Liau LC, Lu RB. The development of an impulsiveness scale: psychometric properties and related to antisocial personality disorder. Chinese J Psychol 2002, 44(1):109-119.
31. Beck AT, Steer RA. Manual for the Revised Beck Depression Inventory. San Antonio, Tex, Psychological Corp 1987,
32. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988, 56:893-897. 10.1037/0022-006X.56.6.893, 3204199.
33. Beck AT, Steer RA. Manual for the Beck Hopelessness Scale. 1988, San Antonio, Tex, Psychological Corp.
34. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intent: the Scale for Suicide Ideation. J Consult Clin Psychol 1979, 47:343-352. 10.1037/0022-006X.47.2.343, 469082.
35. WHOQOL-Taiwan Group Development and manual of the World Health Organization WHOQOL-Taiwan quality of life assessment. 2001, WHOQOL-Taiwan Group.
36. Yao G, Chung CH, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 2002, 101:342-351.
37. Motto An integrated approach to estimating suicide risk. Assessment and Prediction of Suicide 1992, 635-639. New York, Guilford Press, Maris R, Berman L, Maltzberger T, Yufit R, Motto.
38. Malla AK, Norman RMG, Manchanda R. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002, 54:231-242. 10.1016/S0920-9964(01)00254-7, 11950548.
39. Eggers C. Schizoaffective psychoses in childhood: a follow-up study. J Autism Dev Disord 1989, 19:327-343. 10.1007/BF02211850, 2745396.
40. Werry JS, McClellan JM. Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1992, 31:147-150. 10.1097/00004583-199201000-00022, 1537767.
41. David AS. Insight and psychosis. Br J Psychiatry 1990, 156:798-808. 10.1192/bjp.156.6.798, 2207510.
42. Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 1996, 153:799-805.
43. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand Suppl 2000, 401:3-38.
44. Hoff A, Riordan MA, O'Donnell DW, Morris L, De Lisi le. Neuropsychological functioning of first episode schizophreniform patients. Am J Psychiatry 1992, 149(7):898-903.
45. Suvisaari JM, Haukka J, Tanskanen A. Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br J Psychiatry 1998, 173:494-500. 10.1192/bjp.173.6.494, 9926078.
46. Bell MD, Lysaker PH, Milstein RM, Beam-Goulet JL. Concurrent validity of the cognitive component of schizophrenia: Relationship of PANSS scores to neuropsychological assessments. Psychiatry Res 1994, 54:51-58. 10.1016/0165-1781(94)90064-7, 7701028.
47. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychiatry 1998, 12:426-445.
48. Heaton RK, Gladsio JA, Palmer BW, Kuck J, Marcotte TD. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001, 58:24-32. 10.1001/archpsyc.58.1.24, 11146755.
49. Iacono WG, Malone SM, McGue M. Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude. Int J Psychophysiol 2003, 48(2):147-178. 10.1016/S0167-8760(03)00052-7, 12763572.
50. Jeon YW, Polish J. Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications. Psychopathology 2003, 40(5):684-701.
51. Cohen J. Statistical power analysis for the behavioural science. 1988, New York: Erlbaum Hillsdale, 2.
52. Howard R, Castle D, Wessely S, Murray R. A comparative study of 470 cases of early-onset and late-onset schizophrenia. Br J Psychiatry 1993, 157:172-178.
53. Lay B, Blanz B, Hartmann M. The psychosocial outcome of adolescent-onset schizophrenia: a 12-year follow-up. Schizophr Bull 2000, 26(4):801-816.
54. Schultz SK, Ho BC, Andreasen NC. Clinical features characterizing young-onset and intermediate-onset schizophrenia. J Neuropsychiatry Clin Neurosci 2000, 12:502-505.
55. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1996, 154:99-105.
56. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998, 28:165-172. 10.1017/S0033291797005874, 9483693.
57. Hafner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand 2000, 102:44-48. 10.1034/j.1600-0447.2000.00008.x, 10892609.
58. Bender S, Muller B, Oades RD. Conditioned blocking and schizophrenia, a replication and study of the role of symptoms, age, onset-age of psychosis and illness-duration. Schizophr Res 2001, 49:157-170. 10.1016/S0920-9964(00)00040-2, 11343874.
59. Larsen EB, Gerlach J. Subjective experience of treatment, side-effects, mental state and quality of life in schizophrenic outpatients treated with depot neuroleptics. Acta Psychiatr Scand 1996, 96:381-388.
60. Howard R, Rabins PV, Seeman MV, Jeste DV. International Late-Onset Schizophrenia Group. Late-onset schizophrenia and very late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry 2000, 157:172-178. 10.1176/appi.ajp.157.2.172, 10671383.
61. Larsen TK, Joahnnessen JO, Opjordsmoen S. First-episode schizophrenia with long duration of untreated psychosis. Pathway to care. Br J Psychiatry 1998, 172(33):45-52.